Xtrackers MSCI USA ESG Screened UCITS ETF 1C (XRSS)

- Add to watchlist
- Create an alert
- This stock can be held in a




3,830.50p
n/a
4,252.00p
London
3,830.50p
n/a
3,301.50p
n/a
26.50p (0.70%) Previous:
26.50p
n/a
n/a
GBX
ETP Basics
Issuer: | Xtrackers (IE) Plc |
---|---|
Structure: | ETF |
Replication method: | Stocks - Full Replication |
Securities lending: | No |
Number of holdings: | n/a |
Size: | n/a |
Launch date: | 10 June 2014 |
Launch price: | $11.25 |
UCITS: | Yes |
Reporting status: | Yes |
Domicile: | Ireland |
Complex product: | Non-complex |
ISIN: | IE00BJZ2DC62 |
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Please refer to the FCA website for more information.
Annual & interim reports
Before you invest, please make sure you read the documents below
What is a Value Assessment?
Fund Managers are required to regularly assess whether the fund they manage delivers value to investors. When completing their assessment, they will consider investment performance, service offered, costs and charges, and competitor funds. The Assessment of Value for funds is subject to the Financial Conduct Authority's Collective Investment Scheme (COLL) rules or a Price and Value Assessment (PRIN) for other funds not subject to COLL rules.
Why it matters to investors?
The Value Assessment helps an investor understand how a Fund Manager has considered how their fund has delivered value for money or is expected to deliver value for money. The Fund Manager will explain the actions they are taking if their fund has not delivered value for money or it is not expected to deliver value for money.
Value Assessment
Value Assessment review date: | 6 March 2015 |
---|---|
Value Assessment next review date: | - |
Is Assessment of Value required under COLL: | No |
Outcome of COLL Assessment of Value: | n/a |
Outcome of PRIN Value Assessment or review: | - |
Other review related to value and or charges: | Fund costs have been reviewed and are in line with ESMA's briefing on supervision of costs in UCITS and AIFs or relevant NCA supervisory activity |
Further information: | DWS INVESTMENT S.A IS REGULATED BY THE CSSF. ESMA SUPERVISORY BRIEFING ON SUPERVISION OF COSTS IN UCITS AND CSSF SUPERVISORY ACTIVITIES APPLY. FOR INFO ON HOW COSTS ARE CONSIDERED SEE: HTTPS://ETF.DWS.COM/EN-GB/INFORMATION/ETF-DOCUMENTS/OTHER/ |
Ready to invest?
Important Documents
There are no documents available for this stock.
OBJECTIVE
Index: | MSCI USA Select ESG Screened Index |
---|---|
Aim: |
The aim is for your investment to track the performance, before fees and expenses, of...
Read full aim for Xtrackers |
Leverage: | 100% |
Currency hedging: | n/a |
COSTS
Ongoing Charge (OCF/TER): | 0.07% |
---|---|
Management fee: | 0.15% |
Indicative spread: | 0.47% |
In certain cases, where no TER or OCF is shown, additional costs may apply. Please ensure you have read the Key Investor Information Document, Factsheet, Prospectus and any other relevant documentation prior to investing.
Performance
Not available for this stock.
No top ten information is available at this stage |
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.